Julian Yeoh

Julian Yeoh

Auto-generated profile, based on publicly available information

Julian Yeoh

Department of Cardiology, Austin Health, Melbourne, Vic, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JYJulian Yeoh
Julian Yeoh
DCDaan Cottens
Daan Cottens
CCClaudia Cosgrove
Claudia Cosgrove
KMKhaled Mallek
Khaled Mallek
JSJulian Strange
Julian Strange
JSJames Spratt
James Spratt

6 March 2019 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JYJulian Yeoh
Julian Yeoh
JHJonathan Hill
Jonathan Hill
JSJames Spratt
James Spratt

Verified
Journal Article
Open access
PDF file
ANAhthavan Narendren
Ahthavan Narendren
NWNatalie Whitehead
Natalie Whitehead
LBLouise M Burrell
Louise M Burrell
MYMatias B. Yudi
Matias B. Yudi
JYJulian Yeoh
Julian Yeoh
AKAnoop N. Koshy
Anoop N. Koshy
Managing health care for older adults aged 75 years and older can pose unique challenges stemming from age-related physiological differences and comorbidities, along with elevated risk of delirium, frailty, disability, and polypharmacy. This review is aimed at providing a comprehensive analysis of the management of acute coronary syndromes (ACS) in older patients, a demographic substantially underrepresented in major clinical trials. Because older patients often exhibit atypical ACS symptoms, a nuanced diagnostic and risk stratification approach is necessary. We aim to address diagnostic challenges for older populations and highlight the diminished sensitivity of traditional symptoms with age, and the importance of biomarkers and imaging techniques tailored for older patients. Additionally, we review the efficacy and safety of pharmacological agents for ACS management in older people, emphasizing the need for a personalized and shared decision-making approach to treatment. This review also explores revascularization strategies, considering the implications of invasive procedures in older people, and weighing the potential benefits against the heightened procedural risks, particularly with surgical revascularization techniques. We explore the perioperative management of older patients experiencing myocardial infarction in the setting of noncardiac surgeries, including preoperative risk stratification and postoperative care considerations. Furthermore, we highlight the critical role of a multidisciplinary approach involving cardiologists, geriatricians, general and internal medicine physicians, primary care physicians, and allied health, to ensure a holistic care pathway in this patient cohort.

19 May 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
BCBenjamin Cailes
Benjamin Cailes
EHEva-Louise Huber
Eva-Louise Huber
CBClaudia Brick
Claudia Brick
OFOmar Farouque
Omar Farouque
AMAvik Majumdar
Avik Majumdar
AKAnoop N. Koshy
Anoop N. Koshy
Cirrhotic cardiomyopathy (CCM) is an underrecognized risk factor for cardiac events in patients undergoing liver transplantation (LT). Blunted cardiac reserve (BCR) is an emerging indicator of CCM, although it has not been integrated into diagnostic guidelines. This study assesses post-transplant cardiac outcomes and mortality in patients with BCR compared to current CCM diagnostic guidelines, focusing on diastolic indices. Consecutive patients undergoing liver transplant assessment were included. Of 978 patients screened with dobutamine stress echocardiography between 2010-2023, 481 (58.0%) progressed to LT, with 183 (38.0%) meeting BCR criteria and 117 (24.3%) meeting existing CCM diagnostic criteria. Thirty (6.2%) patients suffered a 30-day major adverse cardiovascular event (MACE), and 92 patients (19.1%) died on long-term follow-up. Following multivariate regression analysis, BCR was the strongest independent risk factor for post-operative MACE (HR 2.57 (1.13-5.85), p=0.024), heart failure exacerbations (HR 6.93 (1.46-33.01), p=0.015), and 30-day mortality (HR 9.69 (1.04-92.33), p=0.049). Addition of BCR to the existing guidelines improved MACE prediction (HR 5.81 (1.71-19.76) vs 2.59 (1.15-5.87), p=0.006), with a net reclassification improvement index of 41.9% (p=0.004) compared to existing guidelines alone. These results support the integration of a cardiac reserve assessment into CCM diagnostic criteria, and use in risk stratification of patients undergoing LT.

27 February 2023 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
GHGarry W. Hamilton
Garry W. Hamilton
DDDiem Dinh
Diem Dinh
JYJulian Yeoh
Julian Yeoh
ABAngela L. Brennan
Angela L. Brennan
JFJordan Fulcher
Jordan Fulcher
DCDavid J. Clark
David J. Clark

1 July 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
GHGarry W. Hamilton
Garry W. Hamilton
JTJames Theuerle
James Theuerle
DCDavid Chye
David Chye
JBJayapadman Bhaskar
Jayapadman Bhaskar
SSSiven Seevanayagam
Siven Seevanayagam
OFOmar Farouque
Omar Farouque
BACKGROUND: While transradial access is favored for cardiac catheterization, the radial artery (RA) is increasingly preferred for coronary artery bypass grafting. Whether the RA is suitable for use as a graft following instrumentation for transradial access remains uncertain. METHODS: Consecutive patients from 2015 to 2019 who underwent coronary artery bypass grafting using both the left and right RAs as grafts were included. Instrumented RAs underwent careful preoperative assessment for suitability. The clinical analysis was stratified by whether patients received an instrumented RA graft (instrumented versus noninstrumented groups). Eligible patients with both instrumented and noninstrumented RAs underwent computed tomography coronary angiography to evaluate graft patency. The primary outcome was a within-patient paired analysis of graft patency comparing instrumented to noninstrumented RA grafts. RESULTS: Of the 1123 patients who underwent coronary artery bypass grafting, 294 had both the left and right RAs used as grafts and were included. There were 126 and 168 patients in the instrumented and noninstrumented groups, respectively. Baseline characteristics and perioperative outcomes were comparable. The rate of major adverse cardiac events at 2 years following coronary artery bypass grafting was 2.4% in the instrumented group and 5.4% in the noninstrumented group (hazard ratio, 0.44 [95% CI, 0.12–1.61]; P =0.19). There were 50 patients included in the graft patency analysis. At a median follow-up of 4.3 (interquartile range, 3.7–4.5) years, 40/50 (80%) instrumented and 41/50 (82%) noninstrumented grafts were patent (odds ratio, 0.86 [95% CI, 0.29–2.52]; P >0.99). No significant differences were observed in the luminal diameter or cross-sectional area of the instrumented and noninstrumented RA grafts. CONCLUSIONS: There was no evidence found in this study that RA graft patency was affected by prior transradial access, and the use of an instrumented RA was not associated with worse outcomes in the exploratory clinical analysis. Although conduits must be carefully selected, prior transradial access should not be considered an absolute contraindication to the use of the RA as a bypass graft. REGISTRATION: URL: https://www.anzctr.org.au/ ; Unique identifier: ACTRN12621000257864.